DNA Hypomethylation, Ambient Particulate Matter, and Increased Blood Pressure: Findings From Controlled Human Exposure Experiments

Andrea Bellavia1, Bruce Urch2,3, Mary Speck2,3, Robert D. Brook4, Jeremy A. Scott2,3, Benedetta Albetti5, Behrooz Behbod1, Michelle L. North2,3, Linda Valeri6, Pier Alberto Bertazzi5, Frances Silverman2,3, Diane R. Gold7,1, Andrea Baccarelli1
1Department of Environmental Health, Harvard School of Public Health, Boston, MA
2Division of Occupational and Environmental Health, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
3Gage Occupational and Environmental Health Unit, St. Michael's Hospital, Toronto, Ontario, Canada
4Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI
5Department of Occupational and Environmental Health, Universita' degli Studi di Milano and Fondazione Ca' Granda Policlinico, Milan, Italy
6Department of Biostatistics, Harvard School of Public Health, Boston, MA
7Channing Laboratory, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Tóm tắt

Background Short‐term exposures to fine (<2.5 μm aerodynamic diameter) ambient particulate‐matter ( PM ) have been related with increased blood pressure ( BP ) in controlled‐human exposure and community‐based studies. However, whether coarse (2.5 to 10 μm) PM exposure increases BP is uncertain. Recent observational studies have linked PM exposures with blood DNA hypomethylation, an epigenetic alteration that activates inflammatory and vascular responses. No experimental evidence is available to confirm those observational data and demonstrate the relations between PM , hypomethylation, and BP .

Methods and Results We conducted a cross‐over trial of controlled‐human exposure to concentrated ambient particles ( CAP s). Fifteen healthy adult participants were exposed for 130 minutes to fine CAP s, coarse CAP s, or HEPA ‐filtered medical air (control) in randomized order with ≥2‐week washout. Repetitive‐element ( Alu , long interspersed nuclear element‐1 [ LINE ‐1]) and candidate‐gene ( TLR4 , IL‐12 , IL‐6 , iNOS ) blood methylation, systolic and diastolic BP were measured pre‐ and postexposure. After adjustment for multiple comparisons, fine CAP s exposure lowered Alu methylation (β‐standardized=−0.74, adjusted‐ P =0.03); coarse CAP s exposure lowered TLR4 methylation (β‐standardized=−0.27, adjusted‐ P =0.04). Both fine and coarse CAP s determined significantly increased systolic BP (β=2.53 mm Hg, P =0.001; β=1.56 mm Hg, P =0.03, respectively) and nonsignificantly increased diastolic BP (β=0.98 mm Hg, P =0.12; β=0.82 mm Hg, P =0.11, respectively). Decreased Alu and TLR4 methylation was associated with higher postexposure DBP (β‐standardized=0.41, P =0.04; and β‐standardized=0.84, P =0.02; respectively). Decreased TLR4 methylation was associated with higher postexposure SBP (β‐standardized=1.45, P =0.01).

Conclusions Our findings provide novel evidence of effects of coarse PM on BP and confirm effects of fine PM . Our results provide the first experimental evidence of PM ‐induced DNA hypomethylation and its correlation to BP .

Từ khóa


Tài liệu tham khảo

WHO . Air Quality and Health. Geneva, Switzerland: WHO; 2009.

10.1289/ehp.01109s3389

Office of Air Quality Planning and Standards . Air Now: Action Days. U.S. Environmental Protection Agency; 2011.

10.1161/CIR.0b013e3181dbece1

10.1515/REVEH.2008.23.3.167

10.1016/S0140-6736(10)62296-9

10.1016/j.jash.2009.08.005

10.1161/01.CIR.0000143831.33243.D8

10.1289/ehp.7785

10.1001/archinte.1993.00410050036006

10.1056/NEJM200001063420101

10.1016/S0140-6736(10)62348-3

10.1038/ni887

10.1097/EDE.0b013e3181f20457

10.1164/rccm.200807-1097OC

10.1289/ehp.11898

10.1289/ehp.1002773

10.1158/0008-5472.CAN-06-2995

10.1161/CIRCGENETICS.110.958744

10.1373/49.8.1292

10.1093/nar/gkh739

10.1046/j.1529-8817.2004.00081.x

10.1161/HYPERTENSIONAHA.109.130237

10.1074/jbc.275.13.9773

10.1111/j.1751-7176.2012.00620.x

10.1080/0895-8378.1987.11463191

10.1161/01.HYP.0000229661.06235.08

10.1186/1476-069X-10-45

10.1097/EDE.0b013e31818f69ce

10.1037/1082-989X.11.2.142

10.1097/EDE.0b013e318258f5e4

10.1037/0022-3514.51.6.1173

10.1016/j.mad.2008.12.003

10.1097/MOP.0b013e32832925cc

10.1002/humu.21508

10.1177/1741826711398806

10.1038/8760

10.1291/hypres.25.949

Lovati E, Ferrari P, Dick B, Jostarndt K, Frey BM, Frey FJ, Schorr U, Sharma AM. Molecular basis of human salt sensitivity: the role of the 11beta‐hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab. 1999;84: 3745–3749.

10.1161/CIRCRESAHA.110.237560

10.1042/CS20110523

10.1097/01.hjh.0000163145.12707.63

10.1038/hr.2010.270